Flputnam Investment Management CO Charles River Laboratories International, Inc. Transaction History

Flputnam Investment Management CO

$5.82 Billion
Q3 2024

A detailed history of Flputnam Investment Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Flputnam Investment Management CO holds 3,939 shares of CRL stock, worth $731,748. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,939

Previous 39,925 90.13%

Holding current value

$731,748

Previous $8.25 Million 90.6%

% of portfolio

0.01%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$187.96 - $245.29 $6.76 Million - $8.83 Million	-35,986 Reduced 90.13%	3,939 $775,000
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $4.6 Million - $5.99 Million	-22,286 Reduced 35.82%	39,925 $8.25 Million
Q1 2024 May 03, 2024	BUY	$203.52 - $273.43 $90,159 - $121,129	443 Added 0.72%	62,211 $16.9 Million
Q4 2023 Jan 30, 2024	BUY	$164.52 - $238.84 $706,284 - $1.03 Million	4,293 Added 7.47%	61,768 $14.6 Million
Q3 2023 Nov 06, 2023	SELL	$194.44 - $217.61 $22,166 - $24,807	-114 Reduced 0.2%	57,475 $11.3 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $323,697 - $370,460	-1,762 Reduced 2.97%	57,589 $12.1 Million
Q1 2023 Apr 27, 2023	SELL	$191.89 - $259.92 $58,334 - $79,015	-304 Reduced 0.51%	59,351 $12 Million
Q4 2022 Jan 31, 2023	BUY	$197.11 - $250.07 $613,800 - $778,717	3,114 Added 5.51%	59,655 $13 Million
Q3 2022 Nov 07, 2022	SELL	$182.44 - $250.54 $120,045 - $164,855	-658 Reduced 1.15%	56,541 $11.1 Million
Q2 2022 Aug 08, 2022	BUY	$204.13 - $302.4 $162,283 - $240,407	795 Added 1.41%	57,199 $12.2 Million
Q1 2022 Apr 28, 2022	SELL	$255.51 - $362.11 $3.26 Million - $4.62 Million	-12,749 Reduced 18.44%	56,404 $16 Million
Q4 2021 Feb 15, 2022	SELL	$351.38 - $448.68 $6.88 Million - $8.78 Million	-19,573 Reduced 22.06%	69,153 $26.1 Million
Q3 2021 Oct 26, 2021	SELL	$372.64 - $458.3 $227,683 - $280,021	-611 Reduced 0.68%	88,726 $36.6 Million
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $2.42 Million - $3.06 Million	-8,242 Reduced 8.45%	89,337 $33 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $641,651 - $769,663	-2,570 Reduced 2.57%	97,579 $28.3 Million
Q4 2020 Feb 02, 2021	BUY	$222.0 - $252.62 $3.86 Million - $4.39 Million	17,384 Added 21.0%	100,149 $25 Million
Q3 2020 Nov 03, 2020	SELL	$175.56 - $226.45 $743,145 - $958,562	-4,233 Reduced 4.87%	82,765 $18.7 Million
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $445,650 - $711,450	-3,750 Reduced 4.13%	86,998 $15.2 Million
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $290,864 - $524,497	2,941 Added 3.35%	90,748 $11.5 Million
Q4 2019 Jan 30, 2020	SELL	$126.05 - $152.76 $78,024 - $94,558	-619 Reduced 0.7%	87,807 $13.4 Million
Q3 2019 Nov 05, 2019	SELL	$125.07 - $143.67 $165,842 - $190,506	-1,326 Reduced 1.48%	88,426 $11.7 Million
Q2 2019 Jul 25, 2019	BUY	$123.4 - $148.55 $26,284 - $31,641	213 Added 0.24%	89,752 $12.7 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $41,928 - $58,691	-400 Reduced 0.44%	89,539 $13 Million
Q4 2018 Feb 22, 2019	BUY	$105.09 - $137.23 $109,503 - $142,993	1,042 Added 1.17%	89,939 $10.2 Million
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $52,019 - $62,426	464 Added 0.52%	88,897 $12 Million
Q2 2018 Aug 01, 2018	BUY	$102.37 - $117.25 $13,000 - $14,890	127 Added 0.14%	88,433 $9.93 Million
Q1 2018 May 01, 2018	SELL	$98.19 - $115.2 $1.89 Million - $2.21 Million	-19,219 Reduced 17.87%	88,306 $9.43 Million
Q4 2017 Feb 06, 2018	SELL	$100.43 - $118.09 $1.46 Million - $1.71 Million	-14,499 Reduced 11.88%	107,525 $11.8 Million
Q3 2017 Nov 07, 2017	BUY	$96.72 - $109.26 $11.8 Million - $13.3 Million	122,024	122,024 $13.2 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Account

Flputnam Investment Management CO Charles River Laboratories International, Inc. Transaction History